A small case–control study (Goktas et al, 2005) indicates that plasma adiponectin levels are significantly lower in subjects with prostate cancer than in subjects with benign prostatic hyperplasia or in normal healthy controls. The gene discussed is ADIPOQ; the disease is prostate carcinoma.